Literature DB >> 21522018

Survival in XDR TB: shifting the curve and shifting the paradigm.

Neil A Martinson1, Richard E Chaisson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21522018      PMCID： PMC3125433          DOI： 10.1097/QAI.0b013e31821b4b42

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  17 in total

1.  Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa.

Authors:  Marinus Barnard; Heidi Albert; Gerrit Coetzee; Richard O'Brien; Marlein E Bosman
Journal:  Am J Respir Crit Care Med       Date:  2008-01-17       Impact factor: 21.405

2.  The diarylquinoline TMC207 for multidrug-resistant tuberculosis.

Authors:  Andreas H Diacon; Alexander Pym; Martin Grobusch; Ramonde Patientia; Roxana Rustomjee; Liesl Page-Shipp; Christoffel Pistorius; Rene Krause; Mampedi Bogoshi; Gavin Churchyard; Amour Venter; Jenny Allen; Juan Carlos Palomino; Tine De Marez; Rolf P G van Heeswijk; Nacer Lounis; Paul Meyvisch; Johan Verbeeck; Wim Parys; Karel de Beule; Koen Andries; David F Mc Neeley
Journal:  N Engl J Med       Date:  2009-06-04       Impact factor: 91.245

3.  High early death rate in tuberculosis patients in Malawi.

Authors:  A D Harries; N J Hargreaves; F Gausi; J H Kwanjana; F M Salaniponi
Journal:  Int J Tuberc Lung Dis       Date:  2001-11       Impact factor: 2.373

4.  Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study.

Authors:  Keertan Dheda; Karen Shean; Alimuddin Zumla; Motasim Badri; Elizabeth M Streicher; Liesl Page-Shipp; Paul Willcox; Melanie-Anne John; Gary Reubenson; Darshini Govindasamy; Michelle Wong; Xavier Padanilam; Alicia Dziwiecki; Paul D van Helden; Sweetness Siwendu; Julie Jarand; Colin N Menezes; Avril Burns; Thomas Victor; Robin Warren; Martin P Grobusch; Martie van der Walt; Charlotte Kvasnovsky
Journal:  Lancet       Date:  2010-05-22       Impact factor: 79.321

5.  Extensively drug-resistant tuberculosis (XDR-TB) among health care workers in South Africa.

Authors:  Julie Jarand; Karen Shean; Max O'Donnell; Marian Loveday; Charlotte Kvasnovsky; Martie Van der Walt; Shahieda Adams; Paul Willcox; Justin O'Grady; Alimuddin Zumla; Keertan Dheda
Journal:  Trop Med Int Health       Date:  2010-10       Impact factor: 2.622

6.  Extensively drug-resistant TB in Eastern Cape, South Africa: high mortality in HIV-negative and HIV-positive patients.

Authors:  Charlotte L Kvasnovsky; J Peter Cegielski; Roshen Erasmus; N Olga Siwisa; Khulile Thomas; Martie L van der Walt
Journal:  J Acquir Immune Defic Syndr       Date:  2011-06-01       Impact factor: 3.731

7.  Rapid molecular detection of tuberculosis and rifampin resistance.

Authors:  Catharina C Boehme; Pamela Nabeta; Doris Hillemann; Mark P Nicol; Shubhada Shenai; Fiorella Krapp; Jenny Allen; Rasim Tahirli; Robert Blakemore; Roxana Rustomjee; Ana Milovic; Martin Jones; Sean M O'Brien; David H Persing; Sabine Ruesch-Gerdes; Eduardo Gotuzzo; Camilla Rodrigues; David Alland; Mark D Perkins
Journal:  N Engl J Med       Date:  2010-09-01       Impact factor: 91.245

8.  inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis.

Authors:  A Banerjee; E Dubnau; A Quemard; V Balasubramanian; K S Um; T Wilson; D Collins; G de Lisle; W R Jacobs
Journal:  Science       Date:  1994-01-14       Impact factor: 47.728

9.  Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial.

Authors:  Marcus B Conde; Anne Efron; Carla Loredo; Gilvan R Muzy De Souza; Nadja P Graça; Michelle C Cezar; Malathi Ram; Mohammad A Chaudhary; William R Bishai; Afranio L Kritski; Richard E Chaisson
Journal:  Lancet       Date:  2009-04-04       Impact factor: 79.321

10.  OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice.

Authors:  Makoto Matsumoto; Hiroyuki Hashizume; Tatsuo Tomishige; Masanori Kawasaki; Hidetsugu Tsubouchi; Hirofumi Sasaki; Yoshihiko Shimokawa; Makoto Komatsu
Journal:  PLoS Med       Date:  2006-11       Impact factor: 11.069
View more
  1 in total

1.  Sub-minimum inhibitory concentration of rifampin: a potential risk factor for resuscitation of Mycobacterium tuberculosis.

Authors:  Shahin Pourazar Dizaji; Alireza Taala; Morteza Masoumi; Nayereh Ebrahimzadeh; Abolfazl Fateh; Seyed Davar Siadat; Farzam Vaziri
Journal:  Antimicrob Resist Infect Control       Date:  2017-11-14       Impact factor: 4.887
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.